-
2
-
-
2342604969
-
FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer
-
ix-xxii, 1-229
-
FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 83 Suppl 1 (2003) ix-xxii, 1-229
-
(2003)
Int J Gynaecol Obstet
, vol.83
, Issue.SUPPL. 1
-
-
-
3
-
-
0028106373
-
Ovarian tumors in a cohort of infertile women
-
Rossing M.A., Daling J.R., Weiss N.S., Moore D.E., and Self S.G. Ovarian tumors in a cohort of infertile women. N Engl J Med 331 (1994) 771-776
-
(1994)
N Engl J Med
, vol.331
, pp. 771-776
-
-
Rossing, M.A.1
Daling, J.R.2
Weiss, N.S.3
Moore, D.E.4
Self, S.G.5
-
4
-
-
24644456397
-
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement
-
U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med (2005) 355-361
-
(2005)
Ann Intern Med
, pp. 355-361
-
-
U.S. Preventive Services Task Force1
-
5
-
-
0027998243
-
Parity, age at first childbirth, and risk of ovarian cancer
-
Adami H.O., Hsieh C.C., Lambe M., Trichopoulos D., Leon D., Persson I., et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344 (1994) 1250-1254
-
(1994)
Lancet
, vol.344
, pp. 1250-1254
-
-
Adami, H.O.1
Hsieh, C.C.2
Lambe, M.3
Trichopoulos, D.4
Leon, D.5
Persson, I.6
-
6
-
-
33645418228
-
Induction of ovulation and ovarian cancer: a critical review of the literature
-
Mahdavi A., Pejovic T., and Nezhat F. Induction of ovulation and ovarian cancer: a critical review of the literature. Fertil Steril 85 (2006) 819-826
-
(2006)
Fertil Steril
, vol.85
, pp. 819-826
-
-
Mahdavi, A.1
Pejovic, T.2
Nezhat, F.3
-
7
-
-
0027050477
-
Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group
-
Whittemore A.S., Harris R., and Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 136 (1992) 1212-1220
-
(1992)
Am J Epidemiol
, vol.136
, pp. 1212-1220
-
-
Whittemore, A.S.1
Harris, R.2
Itnyre, J.3
-
8
-
-
0027049550
-
Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group
-
Harris R., Whittemore A.S., and Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136 (1992) 1204-1211
-
(1992)
Am J Epidemiol
, vol.136
, pp. 1204-1211
-
-
Harris, R.1
Whittemore, A.S.2
Itnyre, J.3
-
9
-
-
3042631539
-
Ovarian cancer risk after the use of ovulation-stimulating drugs
-
Brinton L.A., Lamb E.J., Moghissi K.S., Scoccia B., Althuis M.D., Mabie J.E., et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 103 (2004) 1194-1203
-
(2004)
Obstet Gynecol
, vol.103
, pp. 1194-1203
-
-
Brinton, L.A.1
Lamb, E.J.2
Moghissi, K.S.3
Scoccia, B.4
Althuis, M.D.5
Mabie, J.E.6
-
10
-
-
84961043473
-
Clinical effect of human pituitary follicle-stimulating hormone (FSH)
-
Gemzell C.A., Diczfalusy E., and Tillinger G. Clinical effect of human pituitary follicle-stimulating hormone (FSH). J Clin Endocrinol Metab 18 (1958) 1333-1348
-
(1958)
J Clin Endocrinol Metab
, vol.18
, pp. 1333-1348
-
-
Gemzell, C.A.1
Diczfalusy, E.2
Tillinger, G.3
-
12
-
-
50549183277
-
Quantitation of urinary estrogens by gas chromatography
-
Fishman J., and Brown J.B. Quantitation of urinary estrogens by gas chromatography. J Chromatogr 8 (1962) 21-24
-
(1962)
J Chromatogr
, vol.8
, pp. 21-24
-
-
Fishman, J.1
Brown, J.B.2
-
13
-
-
0017038833
-
Therapeutic use of luteinizing hormone-releasing hormone in the human female
-
Nillius S.J. Therapeutic use of luteinizing hormone-releasing hormone in the human female. Curr Top Mol Endocrinol 3 (1976) 93-112
-
(1976)
Curr Top Mol Endocrinol
, vol.3
, pp. 93-112
-
-
Nillius, S.J.1
-
17
-
-
0036468870
-
Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies
-
Ness R.B., Cramer D.W., Goodman M.T., Kjaer S.K., Mallin K., Mosgaard B.J., et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155 (2002) 217-224
-
(2002)
Am J Epidemiol
, vol.155
, pp. 217-224
-
-
Ness, R.B.1
Cramer, D.W.2
Goodman, M.T.3
Kjaer, S.K.4
Mallin, K.5
Mosgaard, B.J.6
-
18
-
-
0033530459
-
Risk of cancer after use of fertility drugs with in-vitro fertilisation
-
Venn A., Watson L., Bruinsma F., Giles G., and Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354 (1999) 1586-1590
-
(1999)
Lancet
, vol.354
, pp. 1586-1590
-
-
Venn, A.1
Watson, L.2
Bruinsma, F.3
Giles, G.4
Healy, D.5
-
19
-
-
0030028328
-
Human menopausal gonadotropin and the risk of epithelial ovarian cancer
-
Shushan A., Paltiel O., Iscovich J., Elchalal U., Peretz T., and Schenker J.G. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 65 (1996) 13-18
-
(1996)
Fertil Steril
, vol.65
, pp. 13-18
-
-
Shushan, A.1
Paltiel, O.2
Iscovich, J.3
Elchalal, U.4
Peretz, T.5
Schenker, J.G.6
-
20
-
-
0343145727
-
Infertility, fertility drugs, and invasive ovarian cancer: a case-control study
-
Mosgaard B.J., Lidegaard O., Kjaer S.K., Schou G., and Andersen A.N. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 67 (1997) 1005-1012
-
(1997)
Fertil Steril
, vol.67
, pp. 1005-1012
-
-
Mosgaard, B.J.1
Lidegaard, O.2
Kjaer, S.K.3
Schou, G.4
Andersen, A.N.5
|